AZ farms out rare disease therapy to Mereo

31st October 2017 Uncategorised 0

AstraZeneca has licensed an experimental rare disease therapy to UK-based Mereo BioPharma, as it continues to shed products outside of its area of strategic focus.

More: AZ farms out rare disease therapy to Mereo
Source: News